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           The internal mucosal surfaces of the human 
body serve many critical biological functions 
such as respiration, digestion, and reproduc-
tion. Pathogens have devised multiple strate-
gies to invade human hosts through mucosal 
surfaces. To counter such microbial attacks, the 
mucosal surfaces are surveyed by specialized 
DCs capable of mounting eff  ective antiviral im-
munity in local lymphoid organs (  1  ). Although 
it was tho  ught that local tissue-resident DCs 
phagocytose microbial antigens and migrate to 
the draining lymph node to prime naive T cells 
(  2  ), this para  digm has been challenged by sev-
eral recent studies in which lymph node  –  resi-
dent DCs were shown to be the only APCs to 
present antigens to T cells (  3  ). In particular, in 
a study using epidermal HSV-1 infection, re-
moval of the infected skin area at early time 
points resulted in diminished CTL responses 
(  4  ). However, beca  use no antigen presentation 
was demonstrated from the migrant DC popu-
lation and the lymph node  –  resident CD8      +   
DCs were exclusively associated with CTL 
priming capacity, the study implied that the 
migrant DCs acted as simple ferries for periph-
eral antigens (  5  ). 
  With respect to the DCs involved in CTL 
priming, the importance of the lymph node  –  resi-
dent CD8      +   DCs has become well accepted (  6  ). 
The CD8      +   DCs have been shown to present 
antigens from other cells (  7  ), and from pathogens 
including HSV-1, infl  uenza virus, vaccinia virus 
(  8  ), lymphocytic choriomeningitis virus, and   Lis-
teria monocytogenes   (  9  ). The exclusive ability of the 
CD8      +   DCs to prime CTL responses was shown 
whether the HSV-1 was injected by a needle into 
the footpad (f.p.) (  10  ), via the intravenous route 
(  8  ), or by dermal abrasion (  11  ). The cellular basis 
for the potent ability of the CD8      +   DCs to pres-
ent antigens on MHC class I (MHC I) could not 
be explained simply by their ability to capture ex-
ogenous antigens. By isolating splenic DCs that 
have captured an equal number of antigen-coated 
beads after systemic administration of labeled beads 
into mice, cross-presentation was shown to be 
much more effi   cient in CD8      +   DCs compared 
with CD8            DCs (  12  ). Further, CD8      +   DCs 
were shown to express higher levels of proteins 
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antigens and pathogen-associated molecular patterns by local 
and lymph node DCs could vary depending on the routes of 
virus administration. For example, it is well known that nee-
dle-injected antigens access distinct regions of the lymph node 
via conduits (  15  ) and are taken up and presented by lymph 
node DCs (  27  ). However, it is unknown how readily antigens 
or viruses access the lymph via mucosal application. To address 
these issues, we examined the population of DCs that present 
viral antigen to CD4 and CD8 T cells in the draining lymph 
nodes after needle, epicutaneous versus mucosal infection with 
HSV-1. Diff  erential contributions of the tissue-derived and 
lymph node  –  resident DCs in antigen presentation to T cells 
were found depending on the route of infection. 
    RESULTS   
  Both CD8      +   and CD8            DCs, but not plasmacytoid DCs 
(pDCs), present viral antigens to CD4 and CD8 T cells after 
mucosal and needle HSV-1 infection with differential kinetics 
  We examined the ability of the DC subsets in presenting viral 
antigens to CD8 T cells in vivo. Because CD8      +   DCs (  10  ) 
and CD8            DCs (  23  ) were shown exclusively to prime CTL 
and Th1 responses after cutaneous and mucosal infection 
with HSV-1 and -2, respectively, to eliminate any variables 
associated with the two types of HSVs used, we focused on 
the priming capacity of DC populations after HSV-1 infec-
tion via f.p. or intravaginal (ivag) inoculation in parallel. This 
allowed critical comparison of the mechanisms involved in 
immune induction after needle subcutaneous injection and 
mucosal infection with the same virus. 
  Three DC subsets were sorted from the draining lymph 
nodes of f.p.- (popliteal) and ivag-infected (inguinal and iliac) mice 
at 20 and 72 h after infection, as described in Fig. S1 (available at 
http://www.jem.org/cgi/content/full/jem.20080601/DC1). As 
reported previously (  10  ), f.p. injection of HSV-1 resulted in 
presentation by CD8      +   DCs as early as 20 h after infection 
(  Fig. 1, A and B  ).   In addition, using a revised DC sorting strat-
egy (Fig. S1), we saw robust antigen presentation by the dou-
ble-negative (DN) DCs to CD8 T cells (  Fig. 1, A and B  ). The 
DCs involved in antigen presentation to CD8 T cells were sim-
ilar whether we used naive gBT-I TCR transgenic CD8 
T cells (  Fig. 1, A, D, G, and J  ) or bulk CD8 T cells from mice 
immunized with HSV-1 (  Fig. 1, B, E, H, and K  ) as the re-
sponder cells. Similar involvement of the respective DC subsets 
was observed for CD4 T cell activation (  Fig. 1 C  ). In contrast, 
no signifi  cant priming by any of the DC subsets was observed 
in the lymph nodes of ivag-infected mice at 20 h after infection 
(  Fig. 1, D  –  F  ). By 72 h, antigen presentation was observed in the 
lymph nodes of mucosally infected mice. Following both routes 
of infection, CD8      +   and CD8            DCs, but not pDCs, were 
found to present viral peptide to CD8 T cells (  Fig. 1, G, H, 
J, and K  ). This was not only true for IFN-     secretion but also 
with respect to the proliferation induced in gBT-I cells by vary-
ing numbers of the sorted DCs used (Fig. S2). Examination of 
the DC subsets that present viral peptides to CD4 T cells revealed 
a very similar pattern: CD8      +   and DN DCs, but not pDCs, pre-
sented viral antigens to CD4 T cells by 72 h (  Fig. 1, I and L  ). 
required for the cross-presentation pathway compared with the 
CD8            population (  13  ). It is unknown how antigens are ac-
quired by the lymph node  –  resident CD8      +   DCs. It is possible 
that the CD8      +   DCs acquire the antigen from the lymph, as an-
tigens injected into the skin can access the draining lymph nodes 
within 30 min (  14, 15  ). After f.p. injection of HSV-1, the virus 
can be found in the draining lymph node from 2  –  24 h after in-
oculation (  16  ). Another possibility is that a population of periph-
eral DCs carry the antigen to the draining lymph node, whereby 
they transfer the antigen to the resident CD8      +   DCs (  17  ), which 
was demonstrated by infection with HSV-1 after dermal abrasion 
(  4  ). The lymph node  –  resident DCs have been shown to acquire 
antigens from other DCs and present such antigens on MHC 
class II (MHC II) (  18  ). In addition, migrant DCs collected from 
infl  uenza-infected mice have been shown to transfer antigen to 
CD8      +   DCs in vitro for presentation to CD8 T cells (  19  ). 
  If migrant DCs act merely as simple ferries, how are 
CD8      +   DCs licensed to prime CTLs? It is clear that CD8      +   
DCs mediate the induction of both tolerance and immunity 
depending on the nature of the encountered antigen (  17  ). For 
CD4 T cell priming, DCs must be activated through the Toll-
like receptor in a cell-autonomous (  20  ) and even in a phago-
some-autonomous (  21  ) manner. For CD8 T cell priming after 
HSV-1 infection, cognate CD4 T cell help is required to li-
cense DCs to activate CTLs (  22  ). Therefore, DCs that contact 
the pathogen and process the microbial information are re-
quired to initiate Th1 responses (  20, 21  ), and the interaction 
of the same DCs with CD4 T cells is necessary for subsequent 
priming of CTLs (  22  ). These fi  ndings suggest that (a) migrant 
DCs must also carry and transfer microbial information to the 
lymph node  –  resident CD8      +   DCs, and that (b) CD8      +   DCs 
must also present viral antigens on MHC II to receive help 
from CD4 T cells. Previous studies have shown that the mi-
grant tissue  –  derived DCs are responsible for priming CD4 T 
cells after mucosal HSV-2 infection (  23  ), subcutaneous anti-
gen inoculation (  14  ), or self-antigens (  24  ). More recently, 
monocyte-derived dermal DCs were shown to migrate to the 
cutaneous lymph nodes and present parasite antigens, and in-
duced protective Th1 responses against   Leishmania major   (  25  ). 
In addition, after lentivirus infection, priming of CD8 T cell 
responses depends on the skin-migrant and not lymph node  –
  resident DCs (  26  ). However, most studies to date examined 
in vivo DC handling of antigen for MHC I or II presentation 
but not both simultaneously, failing to provide an integrated 
picture of antigen presentation by migrant versus resident DCs 
to CD4 and CD8 T cells in the lymph node. 
  A vast majority of the studies to date use needle inocula-
tion of antigens or infectious agents to study the mechanism 
by which immune responses are initiated. However, although 
the use of needles to inject antigens might very well mimic 
priming by vaccines or systemic infection, immune-inductive 
mechanisms defi  ned by needle-injected viruses might not nec-
essarily be applicable to natural infection by the same virus. 
Importantly, the needle-based inoculations of HSV-1 do not 
allow infection of the natural targets of viral replication, namely 
the mucosal epithelial cells. Consequently, the access to viral JEM VOL. 206, February 16, 2009 
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particularly after viral infection (  Fig. 2 A  ). Because NK cells 
contaminate cells gated solely on the CD11c expression (  28  ), 
especially after infl  ammation (  29  ), it is possible that the con-
taminating NK cells in the DN DC gate could hinder the 
ability of these cells to present antigen to CD8 T cells. Indeed, 
removal of the NK cell contamination from the DN DC 
gated cells resulted in robust activation of CD4 and CD8 T 
cells by the DN DCs (  Fig. 2, B and C  ). Thus, throughout the 
rest of the study, we opted to deplete NK cells from our start-
ing population of DCs before fl  ow cytometric cell sorting. 
  CD8            DCs constitute the majority of the APCs 
in the lymph node 
  Having determined the ability of DC subsets to present vi-
ral peptide on a per cell basis, we next wished to examine 
the impact of such presentation by each DC subtype in the 
context of the entire animal. Because antigen presentation 
occurs exclusively in the draining lymph nodes after HSV-1 
infection (  30  ), we focused on the DC subsets within the 
draining lymph nodes after f.p. and ivag infection. First, the 
total number of DCs that accumulate in the draining lymph 
node was assessed. In the steady state, the total numbers of 
DC populations in the one popliteal lymph node drain-
ing the f.p. are signifi  cantly less than those of the vaginal 
draining lymph nodes (mean of iliac and inguinal nodes) be-
cause of diff  erences in the lymph node size. f.p. injection 
of HSV-1 resulted in the accumulation of all DC subsets 
starting at 20 h after infection (  Fig. 3 A  ), whereas mucosal 
Further examination of the three DC subsets revealed that, on 
a per cell basis, pDCs were roughly 10 times less effi   cient in 
stimulating naive CD8 T cell proliferation (Fig. S3 A) and IFN-
     secretion (Fig. S3 B) in vitro after exogenous peptide pulse 
compared with the other two DC subsets. To determine 
whether the diff  erence in the kinetics of antigen presentation 
by the DC subsets depends on the virally infected organ (skin 
vs. vagina) or on the mode of delivery (needle injection vs. 
mucosal inoculation), we examined presentation of viral anti-
gen by lymph node DCs after submucosal needle injection of 
HSV-1 into the vaginal cavity. The kinetics of antigen presen-
tation after needle delivery of the virus into the vagina was sim-
ilar to the needle injection of the virus into the f.p., in that the 
antigens were presented at 20 h (Fig. S4), but diff  ered signifi  -
cantly from the vaginal mucosal infection (  Fig. 1  ). These data 
clearly demonstrated that the kinetics of T cell priming are not 
dictated by the tissue in which the virus is introduced (skin vs. 
vagina) but are dictated by the mode of virus inoculation 
(needle vs. mucosal). 
  To reconcile the diff  erence between these observations 
and previously reported studies, we compared the DC popu-
lations sorted by our method (Fig. S1) to the one described by 
others (  Fig. 2  ) (  8, 10, 11  ).   DC subsets purifi  ed by the latter 
method resulted in CD8 T cell priming activity mainly re-
stricted to the CD8      +   DC population (  Fig. 2 C  ), as shown 
previously (  10  ). Upon further examination, it was found that 
the DN DC population sorted accordingly with the previ-
ously described method was contaminated with NK cells, 
    Figure 1.         Both CD8      +   and CD8                DCs, but not pDCs, present viral antigens to CD4 and CD8 T cells after mucosal and cutaneous HSV-1 
infection.   Groups of mice were infected with 10  6   PFU HSV-1 via f.p. (A  –  C and G  –  I) or ivag (D  –  F and J  –  L) and at 20 h (A  –  F) or 72 h (G  –  L) after infec-
tion, the draining lymph nodes were collected, DCs were enriched, and CD8    +   DCs, pDCs, and DN DCs were sorted as described in Fig. S1 (A and B; 
available at http://www.jem.org/cgi/content/full/jem.20080601/DC1). 25,000 sorted DCs were coincubated with 10  5   HSV-1 – specifi  c naive gBT-I cells 
(A, D, G, and J), bulk effector CD8 T cells (B, E, H, and K), or bulk effector CD4 T cells (C, F, I, and L) for 72 h, and IFN-     secretion was measured. These 
results are representative of three similar experiments. Data are means   ±   SD.   362 MUCOSAL VIRAL ANTIGEN PRESENTATION BY MIGRANT DCS   | Lee et al. 
  Mucosal antigens do not access the lymph 
  It is known that, within 2 h, needle f.p. inoculation of HSV-1 
results in rapid drainage of the virus into the lymph node via 
the lymph (  16  ), whereas ivag infection with HSV-2 does not 
result in direct drainage of the virus into the lymph nodes 
(  23  ). To compare the fate of antigen inoculated via these 
routes, FITC-dextran was injected into the f.p. by needle or 
inoculated intravaginally by pipette. Needle injection resulted 
in rapid access of the antigen to the lymph and to the draining 
lymph node within 30 min (  Fig. 4 A  ), and continued to accu-
mulate for 24 h (  Fig. 4 C  ).   In contrast, ivag inoculation of the 
same antigen resulted in its confi  nement within the vaginal 
mucosal cavity, and no FITC-dextran was detected in the 
draining lymph nodes at either 30 min (  Fig. 4 B  ) or 24 h 
(  Fig. 4 D  ). Thus, these data suggested that the delay observed 
in antigen presentation after ivag inoculation of HSV-1 could 
refl  ect the time required for the virus to replicate within the 
vaginal mucosa, and for local DCs to take up the antigens 
from the infected keratinocytes and migrate into the draining 
lymph nodes. 
  The source of DC populations in the lymph nodes 
  Thus far, our data suggested that both lymph node  –  resi-
dent CD8      +   DCs and DN DCs, the latter consisting of a 
mixture of resident and migratory DCs, contribute to the 
generation of T cell responses after HSV-1 infection. To ex-
amine the contributions of the tissue-migrant versus lymph 
node  –  resident DCs in T cell priming, peripheral DCs were 
labeled with FITC prepared in acetone/dibutyl phthalate 
in the skin (  31  ) or FITC dissolved in DMSO in the vaginal 
cavity, and their migration into the draining lymph nodes 
was assessed. At 72 h, as previously reported (  32  ), both the 
epithelial cell adhesion molecule (EpCAM)  +   Langerhans 
cell (  33  ) and the dermal DC (EpCAM        CD11b  hi  ) popula-
tions contained a signifi  cant fraction of FITC  +   cells from 
the skin (  Fig. 5 A  ).   Similarly, both Langerhans cells as well 
as submucosal DCs were labeled with FITC in the vagina-
draining lymph nodes (  Fig. 5 B  ). Further, we found that 
migrant DCs could be identifi  ed by the high expression 
of CCR7. First, Langerhans cells and dermal-derived DCs 
(FITC  +  ) were CCR7  hi   (  Fig. 5, A and B  ). Second, CCR7  hi   
DCs did not proliferate in response to HSV-1 infection in 
the lymph node (Fig. S6, available at http://www.jem.org/
cgi/content/full/jem.20080601/DC1), consistent with the 
previous description of the migrant DCs (  34  ). Moreover, 
CCR7  lo   DCs did not contain FITC  +   cells after skin and 
vagina labeling (  Fig. 5, A and B  ). The high expression of 
CCR7 by migratory DCs is consistent with the absolute 
requirement of CCR7 for tissue-derived DCs, but not the 
blood-derived DCs, to enter cutaneous lymph nodes (  35  ). 
  Of note, within the non  –  Langerhans cell DC popula-
tion, CD8      +   DCs also contained a substantial fraction of 
FITC  +   cells, which were all CD11b  hi   (  Fig. 5 C  ). In the pe-
riphery, DCs do not express the CD8     molecule in the 
vaginal or skin tissues (Fig. S7, available at http://www.jem
.org/cgi/content/full/jem.20080601/DC1). To distinguish 
HSV-1 infection resulted in the increase in DC subsets 
around 72 h after infection (  Fig. 3 B  ), consistent with the 
kinetics of antigen presentation (  Fig. 1  ).   Notably, the num-
ber of DN DCs always far exceeded the number of CD8      +   
DCs at all time points. Taking into consideration the total 
numbers of these DC subsets, their contributions in both 
CD4 and CD8 T cell priming were calculated on a per 
lymph node basis. This was accomplished by multiplying 
the total number of DCs to the ability of a given popula-
tion of 25,000 sorted DCs to stimulate T cell responses (see 
Materials and methods). This analysis revealed that, because 
of the greater number of DN DCs, the majority of T cell 
priming in the host was mediated by the DN DCs, whereas 
CD8      +   DCs contributed to a lesser extent after f.p. and ivag 
HSV-1 infections (Fig. S5, available at http://www.jem
.org/cgi/content/full/jem.20080601/DC1). 
    Figure 2.         NK cell contamination impairs DN DC presentation of viral 
antigens to CD4 and CD8 T cells.   (A) FACS sorting strategy of DC subsets 
according to previously described methods. CD11c  +   DCs were enriched by 
negative selection of T cells, B cells, granulocytes, and erythrocytes, and were 
labeled with anti-CD11c, anti-CD8, and anti-CD45RA to distinguish pDCs, 
CD8 DCs, and DN DCs (references   8, 10, 11  ). The sorted populations were 
analyzed for the purity of the cell types using anti-MHC II and anti  –  pan-NK 
antibodies (percentages are shown). (B and C) Using the strategy described 
in A, DCs from the draining lymph nodes of f.p. HSV-1  –  infected mice at 72 h 
after infection were sorted and co-cultured with HSV-specifi  c CD4 (B) and 
CD8 (C) T cells for 72 h. IFN-     was measured by ELISA. Antigen presentation 
by DN DC populations containing NK cell contamination (as in A) or purifi  ed 
DN DCs without NK cells was assessed. Similar results were obtained from 
three independent experiments. Data are means   ±   SD. SSC, side scatter.    JEM VOL. 206, February 16, 2009 
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DCs represent TIP DCs. However, it is possible that the 
migrant DCs could represent monocyte-derived DCs (  37  ) 
without the typical feature of the TIP DCs found in   Listeria  -
infected mice. Collectively, these data indicated that CD8      +   
DCs in the infl   amed lymph nodes consist of two types: 
CD8      +   CCR7  hi   CD11b  hi   cells representing tissue-emigrant 
DCs and CD8      +   CCR7  lo   CD11b        cells representing lymph 
node  –  resident DCs. 
  Predominant role of migrant DCs in viral antigen presentation 
after mucosal but not epicutaneous HSV-1 infection 
  In the next set of experiments, we examined the capacity of 
the CD8      +   and CD8            migrant and resident DC popula-
tions in presenting the viral peptide to CD4 and CD8 T cells. 
To track tissue-migrant DCs, we used a previously described 
method to track tissue-migrant DCs after epicutaneous infec-
tion (  4  ) and adopted the procedure for ivag infection. We 
were unable to use this procedure to track migrant DCs after 
needle injection because the needle-injected material bypassed 
the FITC-labeled skin tissue (unpublished data). 4 h after 
whether the CD8      +   CD11b  hi   cells represent lymph node  –
  resident DCs that have picked up FITC from migrant DCs, 
or migrant DCs that have acquired CD8     expression, mice 
were treated with pertussis toxin (PTX) to block G pro-
tein  –  coupled migration (  35  ). The emergence of the CD8      +   
FITC  +   cells was blocked by the PTX treatment (  Fig. 5 D  ). 
However, PTX treatment had no eff  ect on the number of 
the lymph node  –  resident CD8      +   FITC        DCs (  Fig. 5 D  ). 
Further, the time course of the appearance of skin-emigrant 
DCs and the appearance of CD8      +   CD11b  hi   cells in cutane-
ous lymph nodes was found to be concordant (unpublished 
data). To determine the possibility that the migrant DCs 
represent monocyte-derived TNF/inducible NO synthase 
(iNOS)  –  producing DCs (TIP DCs), their expression of 
TNF-     and iNOS, two characteristic functional markers of 
TIP DCs (  36  ), was examined. Although a modest expres-
sion of TNF-     was detected in all DC subsets, this was not 
elevated in the newly migrating DCs (Fig. S8). In addition, 
iNOS expression was not detectable in any of the DCs in 
the lymph nodes, ruling out the possibility that the migrant 
    Figure 3.         Relative numbers of DC subsets in the skin and vagina draining lymph nodes.   Total mean numbers of DCs belonging to the three sub-
sets in the draining lymph nodes of mice (  n   = 5 per group) infected with HSV-1 via the f.p. (popliteal; A) or the ivag (iliac and inguinal; B) route at 0, 20, 
and 72 h after infection were assessed. These results are representative of three similar experiments.     
    Figure 4.         Mucosally applied antigens do not directly access the lymph node.   Mice were injected with FITC-dextran (100   μ  g per mouse) in the 
f.p. by needle (A and C) or into the vaginal cavity with a pipette (B and D). The applied antigen was tracked at the site of inoculation, in the lymph 
draining site of inoculation, and within the draining lymph nodes 30 min (A and B) or 24 h (C and D) later. These fi  gures are representative of three 
similar experiments. Bars, 100   μ  m.     364 MUCOSAL VIRAL ANTIGEN PRESENTATION BY MIGRANT DCS   | Lee et al. 
lower responses compared with ivag infection (Fig. S9 B). In 
contrast, the FITC  +   CD8            DC population was found to be 
the most effi   cient APCs for both CD4 and CD8 T cells after 
ivag HSV-1 infection (Fig. S9 B). 
  To further dissect the role of migrant versus lymph node  –
  resident DCs, we used an established defi  nition of migrant and 
lymph node  –  resident DCs based on the level of CD205 and 
EpCAM expression. Both cutaneous and vagina-draining lymph 
FITC labeling of the skin or vagina (in the absence of irritant), 
mice were infected with HSV-1 epicutaneously (after removal 
of the top skin layer) or intravaginally, and the draining lymph 
node DCs were sorted into FITC  +   versus FITC        DC subsets. 
After epidermal HSV-1 infection, lymph node  –  resident DCs 
were found to be a more dominant APC population for both 
CD4 and CD8 T cells (Fig. S9 A, available at http://www
.jem.org/cgi/content/full/jem.20080601/DC1), albeit at much 
    Figure 5.         Characterization of the migrant versus lymph node  –  resident DC populations in the draining lymph nodes.   Mice were painted on the 
fl  ank skin with 1% FITC solution in acetone (A) or inoculated vaginally with 1% FITC in DMSO (B). At 72 h, draining lymph nodes (popliteal, A; inguinal and 
iliac, B) were collected, and NK cell  –  depleted CD11c  +   DCs were analyzed by FACS. FITC labeling profi  les for EpCAM  +   Langerhans cells or EpCAM        non –
  Langerhans cell DCs are depicted (percentages are shown). (C) CD11c  +   CD8   +   EpCAM       DCs were analyzed by FACS 72 h after FITC painting of the skin and 
FITC inoculation ivag (percentages are shown). (D) Mice were painted on the fl  ank skin with 1% FITC solution in acetone. One group of mice received PTX 
injection at the site of FITC painting 18 h earlier. At 72 h, draining lymph nodes were collected, and DCs were analyzed by FACS for FITC incorporation. 
These fi  gures are representative of three similar experiments.     JEM VOL. 206, February 16, 2009 
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tively, these results indicated that although both migrant and 
lymph node  –  resident DCs present viral antigens to CD4 and 
CD8 T cells, the predominant APCs for CD4 and CD8 T cells 
are the migrant submucosal DCs after mucosal infection. 
  Migrant DCs make contact with HSV-specifi  c T cells 
after mucosal but not skin HSV-1 infection 
  Thus far, our data have demonstrated that the migrant DC 
subsets preferentially present viral antigens to CD4 and CD8 
T cells after mucosal HSV-1 infection ex vivo. To provide in 
vivo evidence for the capacity of tissue DCs to present anti-
gens to T cells after mucosal versus skin infection, we have 
analyzed DC  –  T cell interactions by two-photon microscopy. 
To track tissue DCs into the lymph nodes, we labeled skin and 
vaginal DCs using FITC in DMSO, as described in Fig. S9. 4 h 
later, HSV-1 was applied to the skin or to the vaginal cavity, 
and 48 h after infection, draining lymph nodes were excised 
and fi  xed immediately. DC  –  T cell contact was analyzed by 
nodes contain MHC II  hi  , CD11c  +  , CD8     lo  , CD11b  +  , CD205  int   
(  14, 38  –  41  ) EpCAM        dermal/submucosal DCs (  23, 33  ), and 
MHC II  hi  , CD11c  +  , CD8      int  , CD11b  +  , CD205  hi   (  14, 38  –  41  ) 
EpCAM  +   Langerhans cells (  23, 33  ). To determine the role of 
migrant (Langerhans cells and submucosal DCs) versus lymph 
node  –  resident DN DCs, lymph node cells were fi  rst enriched 
for DCs by depleting T cells, B cells, NK cells, and erythro-
cytes, and CD8      +   DCs and pDCs were excluded by gating out 
the CD8      hi   B220  +   cells (  Fig. 6 A  ).   This allowed us to sort mi-
grant submucosal DCs (CD205  int   EpCAM       ), Langerhans cells 
(CD205  hi   EpCAM  +  ), and lymph node  –  resident DN DCs 
(CD205  lo  ;   Fig. 6 A  ) from the draining lymph nodes of ivag 
HSV-1  –  infected mice; we determined that viral antigens were 
presented predominantly by the submucosal CD205  int   DCs 
and, to a lesser extent, by lymph node  –  resident CD205  lo   DN 
DCs (  Fig. 6 B  ). Langerhans cells, as confi  rmed by the langerin 
staining (  Fig. 6 C  ), failed to present antigen to either CD8 or 
CD4 T cells, consistent with previous reports (  11, 23  ). Collec-
    Figure 6.         Migrant submucosal DCs present viral antigen to both CD4 and CD8 T cells after vaginal HSV-1 infection.   (A) 72 h after ivag HSV-1 
infection or mock infection, draining lymph node NK cell  –  depleted CD8          B220       CD11c +   DCs were sorted into Langerhans cell (EpCAM  +  ), submucosal DC 
(EpCAM        CD205 int  ), and lymph node  –  resident DN DC (CD205  lo  ) populations. The purity of the sorted populations is indicated in the rightmost columns 
(percentages are shown). (B) HSV-1  –  specifi  c CD4 and CD8 T cells were co-cultured with the sorted DC populations from A in the absence of exogenously 
added antigens. IFN-     secretion from T cells was measured after 72 h of culture by ELISA. These data are representative of three similar experiments. Data 
are means   ±   SD.  (C)  EpCAM +  -sorted DCs (as in A, top row) were stained intracellularly with antilangerin or with an isotype control.     366 MUCOSAL VIRAL ANTIGEN PRESENTATION BY MIGRANT DCS   | Lee et al. 
ulate CD4 T cell activation after HSV-2 ivag infection (  23  ). 
However, we showed in this paper that the majority of this 
activity comes from the migrant CD8      +   DCs (Fig. S9 B). 
Thus, the overall conclusion that migrant submucosal DCs 
contribute signifi  cantly to CD4 T cell priming after vaginal 
infection remains valid for both HSV-2 and HSV-1. 
  Our observation that migrant DCs directly present pep-
tides on MHC I to CD8 T cells is not without precedence. 
Skin-migrant DCs have been shown to present skin-derived 
antigen to CD8 T cells to induce activation (  46  ) or tolerance 
(  47  ). A non-CD8      +   DC population, particularly the dermal 
DC subset, in presenting antigen to both CD8 and CD4 T cells 
was demonstrated after f.p. injection of infl  uenza virus (  45  ). By 
tracking skin-migrant DCs with FITC, He et al. demonstrated 
that the migrant DCs directly presented lentiviral-encoded an-
tigen to CD8 T cells in the draining lymph nodes (  26  ). In this 
study, the authors attributed the ability of the migrant DCs to 
present lentiviral antigen to the nonlytic nature of the lentivi-
rus. It is thought that a lytic virus such as HSV-1 renders di-
rectly infected DCs incapable of participating in CTL priming 
(  26, 48  –  51  ). Therefore, our data showing that migrant submu-
cosal DCs present HSV-1 antigens in the draining lymph nodes 
likely refl  ect antigen presentation by DCs that are not directly 
infected by the virus, but rather by those that acquired the viral 
antigens from the infected keratinocytes at the site of infection. 
This hypothesis is supported by the fact that there was no evi-
dence of infected DCs that migrated to the draining lymph 
node after vaginal HSV-2 infection (  23  ). Thus, extending on the 
previous fi  nding with a nonlytic virus (  26  ), the present study 
demonstrates that noninfected migrant submucosal DCs di-
rectly prime T cell responses after natural mucosal infection 
with HSV-1 by 72 h after infection. 
  It has long been thought that CD8      +   DCs exclusively arise 
from blood-derived precursors. Although it is true that the 
majority of the CD8      +   DCs in the spleen derive from a blood 
precursor and not by conversion of mature CD8            DCs into 
CD8      +   DCs (  52  ), the expression of the CD8     molecule on 
tissue-derived DCs in the peripheral lymph node remains less 
clear. The Langerhans cells have been reported to up-regulate 
CD8     expression upon maturation (  53, 54  ). In other species 
such as the rat, cow, or sheep, lymph DCs include signal-regu-
latory protein       –  negative and   –  positive populations, which 
correspond to the CD8      +   and CD8            DC populations in the 
mouse, respectively (  55  ). More recently, skin-migrant DCs 
that secrete IL-12 p40 upon cutaneous LPS or   L. monocytogenes   
injection were shown to express CD8     (  56  ). These cells are 
not present under a steady-state condition in the cutaneous 
lymph nodes, and appear to require infl  ammation-induced 
migration from the skin. Our data demonstrated that the mi-
grant DCs clearly contained a CD8      +   population that coex-
pressed CD11b. By sorting migrant versus lymph node –  resident 
DC populations after ivag HSV-1 infection, we found that the 
T cell priming activity was detected mainly in the CD8            
FITC  +   migrant DCs. 
  Our data demonstrated that nonmigrant lymph node  –  resi-
dent DCs also present viral antigen after mucosal infections. 
two-photon microscopy using Volocity software after gener-
ating volume renderings of image stacks (see Materials and 
methods). Enumeration of the DC  –  T cell conjugate in the re-
spective lymph nodes revealed that higher frequencies of 
T cells make contact with migrant DCs after mucosal than 
epicutaneous infection (Fig. S10, available at http://www.jem
.org/cgi/content/full/jem.20080601/DC1). Thus, these data 
indicated that migrant DCs interact with virus-specifi  c CD8 T 
cells more frequently upon mucosal HSV-1 infection com-
pared with skin infection, and support the notion that migrant 
DCs are directly involved in the priming of cognate T cells af-
ter mucosal viral infection in vivo. 
    DISCUSSION   
  In this study, we examined the contributions of DC popula-
tions in priming CTL and Th1 responses to HSV-1 infection 
after needle/epidermal and mucosal inoculations. Our results 
demonstrated that needle injection of the virus resulted in 
rapid acquisition of antigens by DCs in the lymph node, pre-
sumably by uptake of the lymph-borne virus in situ (  27  ). In 
contrast, after mucosal infection with HSV-1, antigen-pre-
senting DCs were only found in the draining lymph nodes 
after 72 h of infection, consistent with the requirement for 
migrant DCs to carry viral antigens to the draining lymph 
nodes. Examination of the DC subsets  ’   abilities to prime T cell 
responses revealed that although both CD8      +   and CD8            
DCs presented viral antigens to both CD8 and CD4 T cells, 
the predominant APCs were the migrant CD8            submucosal 
DCs after mucosal infection and lymph node –  resident CD8     +   
and DN DCs after cutaneous infection. These conclusions 
were also supported by our in vivo analyses of the interaction 
between the migratory DCs with HSV-specifi  c CD8 T cells 
by two-photon microscopy. Migratory DCs were found in 
contact with cognate T cells more frequently after vaginal 
HSV infection than epicutaneous infection. 
  In contrast to previous studies (  8, 10, 11  ), our results 
demonstrated the role for CD8            DN DCs as APCs to CTLs 
after HSV-1 infection. A plausible explanation for the diff  er-
ences is the manner in which the DN DCs were sorted. As 
shown in   Fig. 2  , NK cell contamination interfered with the 
function of DN DCs. The mechanism by which NK cells in-
hibit the ability of DCs to stimulate CD8 T cells is unknown. 
Second, our data demonstrated the lack of antigen presenta-
tion by pDCs. A study has demonstrated the role of pDCs in 
CD4 T cell priming in the cutaneous lymph nodes using 
diphtheria toxin  –  mediated depletion of conventional DCs 
(cDCs) (  42  ). Thus, in the absence of cDCs, pDCs might have 
a compensatory role in presenting antigens to T cells. How-
ever, our data demonstrated that in an intact mouse, pDCs do 
not normally participate in the priming of T cells. These data 
are consistent with previous reports demonstrating the role of 
pDCs as helpers of antigen-presenting cDCs (  43  ) but not as 
direct presenters of antigens to T cells in the draining lymph 
nodes (  44, 45  ). Third, we demonstrated the role of CD8      +   
DCs in antigen presentation to CD4 T cells. In our previous 
study, we did not observe the ability of CD8      +   DCs to stim-JEM VOL. 206, February 16, 2009 
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  MATERIALS AND METHODS 
  Animals.     6  –  8-wk-old female C57BL/6 mice were obtained from the 
National Cancer Institute. gBT-I transgenic mice, which express a TCR 
(V    2V    8.1) specifi  c for the immunodominant epitope of HSV gB protein 
(gB  498-505  ) (  61  ), was a gift of C. Jones and F. Carbone (University of Mel-
bourne, Victoria, Australia), and W. Heath (Walter and Eliza Hall Institute 
of Medical Research, Victoria, Australia). All procedures used in this study 
complied with federal guidelines and institutional policies, and were ap-
proved by the Yale Animal Care and Use Committee. 
  Virus and infection.     The HSV-1 KOS strain was provided by D. Knipe 
(Harvard Medical School, Boston, MA). HSV-1 was propagated and titered 
by a plaque assay on Vero cells. Vaginal virus infection was performed with 
10  6   PFU HSV-1, as previously described (  23  ). For submucosal vaginal viral 
injection by needle, mice were anesthetized and injected with 10  6   PFU 
HSV-1 in a 20-  μ  l volume into the submucosal tissue of the vaginal cavity by 
a 27G  5  /  8   needle (BD). For subcutaneous infection, mice were injected with 
10  6   PFU HSV-1 in a 20-  μ  l volume into the hind f.p. by a 27G  5  /  8   needle. For 
epicutaneous infection, mice were anesthetized, and the backs of mice were 
shaved with a hair clipper and depilated by hair remover lotion (Nair). Ac-
cording to a previously established method (  62  ), small abrasions of     5-mm  2   
areas were made to remove only the top skin layer using a handheld motor-
ized pedicure/manicure instrument (HoMedics, Inc.). No damage to the 
microvasculature or dermis was observed. 10  6   PFU HSV-1 was applied on 
the abraded skin in a 10-  μ  l volume per site. 
  DC isolation and sorting.     The draining lymph nodes were removed from 
mice infected at the time periods indicated in the fi  gures, and were cut into 
small fragments using razor blades and digested in 2 mg/ml collagenase D 
(Roche) and 30   μ  g/ml DNase I (Roche) at 37  °  C for 30 min. The cells were 
resuspended in HBSS containing 5% FBS and 5 mM EDTA and were incu-
bated at 37  °  C for 5 min. Single cells were prepared by a 70-  μ  m cell strainer 
(BD) and were incubated for 15 min at 4  °  C with a mixture of rat anti-CD3 
(17A2; BD), anti-Thy1 (G7; BD), anti-CD19 (1D3; BD), and antierythro-
cyte (TER119; BD). Cells were incubated with goat anti  –  rat IgG  –  coated 
Dynabeads (Invitrogen) under continuous shaking for 20 min at 4  °  C. Bead-
absorbed cells were removed using a Dynal magnet (Invitrogen). Nonde-
pleted cells were stained with anti  –  pDC antigen 1 (PDCA-1)  –  FITC 
(Miltenyi Biotec), anti-B220  –  PE (RA3-6B2; eBioscience), anti-CD8      –
  PerCP (53-6.7; BD), anti-CD11c  –  allophycocyanin (HL3; BD), anti  –  pan-
NK  –  biotin (DX5; eBioscience)/streptavidin  –  Pacifi  c blue, and anti  –  MHC II 
(I-A/I-E; M5/114.15.2; eBioscience) antibodies conjugated by a SAIVI Al-
exa Fluor 680 antibody labeling kit (Invitrogen) after incubating for 10 min 
at 4  °  C in the presence of anti-CD16/32 (2.4G2; BD) antibody to block Fc 
receptors. Stained cells were sorted by FACSAria and analyzed with an LSR 
II (BD). The six-color sorting strategy allowed us to defi  ne CD8      +   DCs 
as CD11c  +  /MHC II  +  /B220       /CD8      +  /PDCA-1       /DX5        cells, pDCs as 
CD11c  int  /MHC II  int  /B220  +  /PDCA-1  +  /DX5        cells, and DN DCs as CD11c  +  /
MHC II  +  /B220       /CD8           /PDCA-1       /DX5        cells. Sorted DCs were cul-
tured in RPMI 1640 (Invitrogen) containing 10% FBS (Invitrogen), 50   μ  M 
    -mercaptoethanol, 100 U/ml penicillin (Invitrogen), and 100   μ  g/ml strep-
tomycin (Invitrogen) in 96-well U-bottom plates (BD). Postsort DC popu-
lations were analyzed for MHC II expression or isotype control labeling as 
shown in Fig. S1 B. For the experiments depicted in   Fig. 2  , DCs were iso-
lated as previously described (  8, 10, 11  ), with the exception for data pro-
vided in the third columns of panels B and C, where NK cells were 
specifi  cally depleted from the DN DC gate. For the experiments presented 
in   Fig. 6  , enriched DCs depleted of B cells, T cells, NK cells, and erythro-
cytes by Dynal beads were stained with anti  –  MHC II  –  FITC, anti-CD205  –
  PE (Cedarlane Laboratories), anti-CD8      –  PerCP, anti-B220  –  PerCP (BD), 
anti-CD11c  –  allophycocyanin, anti-CD11b (M1/70; eBioscience)  –  allophy-
cocyanin  –  Cy7, and anti-EpCAM  –  Alexa Fluor 680. CD11c  +   B220        CD8            
DCs were further sorted into EpCAM  +   (Langerhans cells), EpCAM        
CD205  int   (submucosal DCs), or EpCAM        CD205  lo   (DN DCs) populations. 
Postsort analyses indicate   >  95% purity of all DC populations. 
Because viral antigens do not access the lymph node directly 
after mucosal infection, antigen might have been transferred 
from the migrant DCs (  4  ). It is also known that cell-associated 
antigens are transferred to endogenous CD8      +   DCs in the 
spleen (  18  ). In the case of cell-associated antigens, cutaneous 
inoculation of BM DCs loaded with nondegradable beads 
were found to transfer beads to endogenous lymph node DCs 
almost completely within 1 wk (  34  ). Unlike these examples, 
because antigens associated with pathogens are likely to be 
degraded within 20 h to peptides within the DCs (  57  ), and 
because processed peptides are not ideal substrates for cross-
presentation (  58  ), during infection, only degradation-resistant 
antigens may be transferred to lymph node  –  resident DCs for 
cross-presentation. Further studies are needed to unveil the na-
ture of antigen transfer in vivo. To this end, an elegant recent 
study showed cooperation between lymph node  –  resident DCs 
and migrant DCs in CD4 T cell priming (  59  ). Allenspach et al. 
demonstrated that lymph node  –  resident DCs are required to 
initiate activation and trapping of cognate T cells, whereas mi-
gratory DCs are required to induce proliferation. Our data are 
consistent with their observation in that both lymph node  –  res-
ident and migrant DCs presented viral antigens regardless of 
the route of infection. Our observation of migrant DCs being 
the dominant APCs to present antigens after mucosal infection 
may be explained by the extent of antigenic availability in the 
peripheral tissue, with highly abundant antigens being pre-
sented more readily by the migrant DCs (  3  ). Our data are con-
sistent with this notion, because compared with the localized 
dermal abrasion  –  based HSV-1 infection, ivag HSV-1 inocula-
tion results in the infection of the entire vaginal epithelial layer, 
producing very high titers of virus in the vaginal mucosa, re-
sulting in a much more robust T cell priming compared with 
epicutaneous infection (Fig. S9 B). This could explain why the 
lymph node  –  resident DCs were the dominant APCs for CD8 
T cells after dermal abrasion (Fig. S9 A) (  4  ) compared with the 
case of mucosal infection in which the viral antigens are pre-
sented by the migrant DCs. 
  In conclusion, this study demonstrated the involvement of 
multiple DC types in T cell priming. The redundancy found in 
this system may refl  ect the necessity to ensure robust antigen 
presentation after viral infection. It may also refl  ect the require-
ment of these diff  erent DC subsets to perform distinct func-
tions within the lymph node to optimally stimulate T cells (  59  ). 
It is known that migrant DCs and lymph node  –  resident DCs 
diff  erentially interact with conduits (  27  ), endothelial cells, and 
T cells in distinct locations within the lymph node (  60  ). In ad-
dition, migrant DCs are directly stimulated by innate recogni-
tion of pathogens in the periphery, whereas the lymph node 
DCs rely on the information carried by migrant DCs. The pre-
cise role of these DC subsets in fi  ne tuning T cell responses re-
mains to be resolved by future studies. The results of this study 
have signifi  cant implications in the strategies to design vaccines 
against pathogens and for immunotherapeutic approaches to 
treat cancer. For mucosal vaccines, our data support the strat-
egy of steering the local DC populations to prime the type of 
eff  ector responses needed in the draining lymph nodes. 368 MUCOSAL VIRAL ANTIGEN PRESENTATION BY MIGRANT DCS   | Lee et al. 
populations from the draining lymph nodes of mice infected with HSV-1 at 
72 h after infection. T cell proliferation was measured by   3  H incorporation 
after adding 0.5   μ  Ci thymidine per well starting at 48 h of incubation, and 
radioactivity was counted at 72 h. 
  BrdU labeling of DCs in vivo.     Mice were given 1 mg BrdU in PBS by intra-
peritoneal injection at 48 h after infection and were maintained with 0.8 mg/ml 
BrdU in drinking water for the duration of study. At 72 h after infection, iliac 
lymph nodes were isolated, and single cells were stained with anti  –  pan-NK 
(DX5)  –  PE, anti-CCR7  –  allophycocyanin, and anti-CD11c  –  PECy7 (N418). 
Intracellular BrdU was stained by an anti-BrdU  –  FITC labeling kit (BD). 
  Assessment of CD8     expression on peripheral tissue DCs.     Excised 
ear and vaginal tissue were incubated in 2 mg/ml Dispase II (Roche) for 45 
min at 37  °  C, which allows separation of epidermal sheets and vaginal epithe-
lium from the dermis and lamina propria, respectively. These tissues were cut 
into small pieces and were further digested with 0.1 mg/ml collagenase D in 
IMDM (Invitrogen) containing 10% FCS for 30 min at 37  °  C. To analyze the 
population in the skin dermis and the lamina propria of the vagina, these tis-
sues were cut into small pieces and were further digested with 0.425 mg/ml 
collagenase D, 100 U/ml hyaluronidase (Sigma-Aldrich), and 30   μ  g/ml DN-
ase I (Sigma-Aldrich) for 60 min. These digested pieces were minced and fi  l-
tered through a nylon mesh, and the resulting cells were fi  ltered through a 
70-  μ  m fi  lter. Single suspensions pretreated with anti  –  Fc receptor antibody 
(eBioscience) were stained with CD11c, MHC II, and CD8    . 7-AAD was 
added to the cells immediately before analysis, and 7-AAD  +   dead cells were 
excluded from analysis. 
  Migratory DC sorting.     For FITC tracking experiments after epicutaneous 
infection, FITC was painted on the abraded areas of the skin, and 4 h later, 10  6   
PFU HSV-1 was applied to the painted sites. For tracking experiments after 
ivag infection, mice were fi  rst injected ivag with a 10-  μ  l volume of 1% FITC 
solution in DMSO. 4 h later, mice were inoculated ivag with 10  6   PFU HSV-1. 
At 72 h after infection, brachial (for skin), and iliac and inguinal (for ivag) 
lymph node cells were isolated and enriched for DCs by depleting B cells, 
T cells, NK cells, and erythrocytes with Dynabeads, as described previously in 
Materials and methods, and were stained with anti  –  MHC II  –  PE, anti-CD8      –
  PE  –  Cy7, anti-CD11c  –  allophycocyanin, and anti-EpCAM  –  Alexa Fluor 680. 
Stained cells were sorted by a FACSAria. 
  Two-photon laser scanning microscopy and three-dimensional 
volume rendering of excised lymph nodes.     After the adoptive transfer 
of 5   ×   10  5   CMRA (CellTracker Orange; Invitrogen)-labeled gBT-I T cells 
the day before infection, HSV-1 was epicutaneously applied to the skin or 
inoculated by pipette to the vaginal cavity after FITC labeling, as described 
in Fig. S9. A fl  uorescence microscope (model BX61WI; Olympus) in com-
bination with a 20  ×   0.95NA objective (Olympus) and a multiphoton mi-
croscopy system (LaVision Biotec) was used for imaging of the excised 
lymph nodes. An autotunable titanium-sapphire multipass laser (Chame-
leon XR; Coherent) pumped by a 12W Verdi laser source was used for the 
excitation light source. Emitted light was collected with nondescanned de-
tectors outfi  tted with the following bandpass fi  lters: 435/90 nm (for the 
second harmonic emission of collagen fi  bers), 525/50 nm (for FITC), and 
615/100 nm (for CellTracker Orange). Stacks of either 51 or 101 optical 
sections with a 1-  μ  m z spacing were acquired with the laser set at a wave-
length of 820 nm. The fi  eld of view for each xy plane was either 150   μ  m, 
at a resolution of 0.3   μ  m per pixel, or 300   μ  m, at a resolution of 0.59   μ  m 
per pixel. Volocity software (PerkinElmer) was used to generate volume 
renderings of image stacks. 
  Online supplemental material.     Fig. S1 depicts cell-sorting strategies to 
obtain pure DC populations from lymph nodes. Fig. S2 shows the prolifera-
tion of gBT-I induced by ex vivo  –  purifi  ed DC subsets. Fig. S3 shows the 
relative capacities of DC subsets in stimulating naive CD8 T cell prolifera-
tion in vitro. Fig. S4 shows antigen presentation by DC subsets after ivag 
  T cell activation by sorted draining lymph node DCs.     Naive gBT-I 
CD8 T cells were isolated from single-cell suspensions of lymph nodes from 
the gBT-I TCR transgenic mice using the CD8 T cell isolation kit (Miltenyi 
Biotec) according to the manufacturer  ’  s instructions. Anti-HSV CD4 and 
CD8 T cells were isolated from the inguinal and iliac lymph nodes of day 7 
ivag HSV-1  –  infected mice using anti-CD4 or anti-CD8-microbeads (Mil-
tenyi Biotec). 2.5   ×   10  4   FACS-sorted DCs were incubated with 10  5   CD4 or 
CD8 T cells for 72 h at 37  °  C. IFN-     production in supernatants was mea-
sured by ELISA. 
  FITC-dextran injection.     100   μ  g FITC-dextran (500,000 mol wt with 90 mol 
of dye per dextran; Invitrogen) was subcutaneously injected into hind f.p. by 
needle or inoculated into the vaginal cavity by a blunt-ended micropipette 
tip. 30 min or 24 h later, the vagina, f.p., and popliteal and iliac lymph nodes 
were isolated and embedded into optimum cutting temperature media. 
Cryosections were labeled with DAPI to visualize the nuclei. In addition, to 
examine FITC-dextran in the lymphatic vessels, a midline incision was made 
along the ventral surface of the abdominal cavity, and the skin was collected 
and analyzed by a fl  uorescence microscope. 
  Tracking of migrant DCs by FITC painting.     Mice were anesthetized, 
shaved with a hair clipper, and depilated. Such areas of the skin were painted 
with 100   μ  l of a 1% FITC solution in acetone/dibutyl phthalate (1:1 ratio; 
Sigma-Aldrich). The brachial lymph nodes were isolated, and single-cell sus-
pensions were prepared as described in DC isolation and sorting. In some 
experiments, 0.5   μ  g PTX was intradermally injected daily on the FITC-
painted area to inhibit cell migration. For FITC ivag inoculation, 1% FITC 
solution in DMSO was inoculated into the vaginal cavity, and the draining 
iliac and inguinal lymph nodes were isolated at the time points indicated in 
the fi  gures, and single-cell suspensions were prepared as described. Isolated 
lymph node cells were fi  rst enriched for DCs by depleting NK cells, T cells, 
B cells, and erythrocytes, and were stained with anti-CD11b  –  PE (M1/70), 
anti-CD8  –  PerCP, anti-CCR7  –  allophycocyanin (4B12; eBioscience), anti-
CD11c (N418; eBioscience)  –  PE  –  Cy7, and MHC II (eBioscience)  –  Alexa 
Fluor 680 or anti-EpCAM (G8.8; BD)  –  Alexa Fluor 680, which were con-
jugated by the SAIVI Alexa Fluor 680 antibody labeling kit. 
  Assessment of the contributions of DC subsets per lymph node.     The 
contributions of each DC subset in presenting viral peptides to CD8 and 
CD4 T cells were calculated by multiplying the ability of the sorted DC sub-
set (25,000 DCs) to stimulate production of IFN-     from responder T cells. 
For example, at 72 h after f.p. infection, the DN DC number in the popliteal 
lymph node was 2.5   ×   10  5   (  Fig. 3 A  ). It was found that 1,230 pg/ml IFN-     
was secreted from 10  5   CD8 T cells incubated with 25,000 DN DCs isolated 
from the popliteal lymph node at 72 h after f.p. infection (  Fig. 1 H  ). Thus, the 
contribution of the DN DCs in antigen presentation to CD8 T cells at this 
time point was calculated as follows: 1,230 pg/ml IFN-    /25,000 sorted DN 
DCs   ×   2.5   ×   10  5   DN DCs per lymph node = 12,300 pg/ml IFN-     induced 
by DN DCs per lymph node. 
  gBT-I T cell proliferation.     Naive gBT-I CD8 T cells were isolated from 
single-cell suspensions of lymph nodes from the gBT-I TCR transgenic 
mice using the CD8 T cell isolation kit according to manufacturer  ’  s instruc-
tions. Purifi  ed gBT-I CD8 T cells were labeled with 5   μ  M CFSE (Invitro-
gen) for 10 min at 37  °  C. Sorted DCs were incubated with 3   μ  M gB peptide 
for 1 h at 37  °  C and washed three times in PBS. gB peptide  –  pulsed DCs were 
mixed with unpulsed DCs at various ratios (the total DC number was kept 
constant at 10  5   DCs/well), and were co-cultured with 5   ×   10  4   gBT-I CD8 
T cells for 72 h at 37  °  C. Cells in the CD8  +  /V    2  +   gate were analyzed as 
gBT-I cells after staining with anti-V    2  –  PE (B20.1; BD) and anti-CD8      –
  allophycocyanin (53-6.7; eBioscience), after excluding dead cells by 7-ami-
noactinomycin D (7-AAD). CFSE dilution was analyzed by a FACSCalibur 
(BD). IFN-     production from supernatants was measured by ELISA accord-
ing to the manufacturer  ’  s instructions (eBioscience). In the experiments de-
scribed in Fig. S2, 10  5   naive gBT-I cells were stimulated by sorted DC JEM VOL. 206, February 16, 2009 
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